Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23551580 | 1.00 | DDB1 (0.59) | DDB1CRBN | |
| SCHEMBL31102040 | 0.87 | DDB1 (0.59) | DDB1CRBN | |
| SCHEMBL31101661 | 0.87 | DDB1 (0.59) | DDB1CRBN | |
| SCHEMBL31100604 | 0.87 | DDB1 (0.66) | DDB1CRBN | |
| SCHEMBL31100932 | 0.87 | DDB1 (0.59) | DDB1CRBN | |
| SCHEMBL24890782 | 0.83 | DDB1 (0.68) | DDB1CRBN | |
| SCHEMBL21946764 | 0.83 | DDB1 (0.68) | DDB1CRBN | |
| SCHEMBL31099665 | 0.83 | DDB1 (0.51) | DDB1CRBN | |
| SCHEMBL31102097 | 0.82 | DDB1 (0.52) | DDB1CRBN | |
| SCHEMBL24955737 | 0.81 | DDB1 (0.56) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023287928-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY | NURIX THERAPEUTICS, INC. (US) | 2023-01-19 | — | — | WO | disclosed |